US News

Phizer (NYSE:PFE) has officially withdrawn it’s £69 billion offer to acquire British pharmaceutical giant, AstaZeneca (LSE:AZN). According to a statement from Pfizer on 26 May, the deal has been withdrawn and, therefore, will not happen at any time in the near future, if ever. The text of Pfizer’s announcement read: On 18 May 2014, Pfizer announced […]

The latest offer from Pfizer (NYSE:PFE) for AstraZeneca (LSE:AZN) (NYSE:AZN) has turned into a Phizaster. No matter how loudly one shouts “No,” it usually causes other voices to cry out in protest. Whilst the original “No” was directed at Pfizer, now the AZN board is saying “No” to its own shareholders. That’s probably not a […]

Dividend of $0.15 Per Share Flushing Financial Corporation (Nasdaq:FFIC), the parent holding company for Flushing Bank, today announced that the Board of Directors declared a quarterly dividend on its common stock of $0.15 per common share, payable on June 27, 2014 to shareholders of record at the close of business on June 6, 2014. John […]

Relates to Common Stok Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the pricing of an underwritten public offering of 7,300,000 shares of its common stock at a price to the public of $14.22 per share. The gross proceeds to Chimerix from this offering, […]

Extended to US$2.75m Magnolia Petroleum Plc, the AIM quoted US onshore focused oil and gas exploration and production company, has announced the borrowing base limit of its Credit Facility has been increased to US$2.75 million from US$2.1 million. This development follows the recent increase in the value of the Company’s net attributable proved and developed […]

The biggest financial news of the day, for me at least, is that the new company, formerly known as Glencore Xstrata (LSE:GLEN), and known before that as two companies, i.e., Glencore and Xtrata, shall now henceforth officially be called Glencore. Its EPIC ID will still be GLEN. The impact of the announcement at the company’s […]

It took less than 24 hours, most of which, I assume, AstraZeneca’s (LSE:AZN) chairman, Leif Johansson spent getting a good night’s sleep, to resoundingly reject Pfizer’s (NYSE:PFE) latest and final takeover offer of £55.00 per share. AZN share price has dropped by more than 11% to £42.75. Pfizer made it abundantly clear yesterday, 18 May, that £55.00 per […]

A real-life hot stock rocket? Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, has received a contract from Stratolaunch Systems Corporation (SSC) to provide six RL10C-1 production engines, with an option to provide an additional six RL10C-1 production engines at a later date, for the third stage of a revolutionary commercial air-launch system. The inaugural launch of […]

Changed to Wee-Cig International Corporation Legacy Platinum Group Inc. (OTCPINK:LWSP) reports that the company has changed its name to Wee-Cig International Corporation (Wee-Cig) and its symbol to WCIG to reflect its new business direction. A Certificate of Amendment to its Articles of Incorporation was filed with the State of Nevada changing the name to Wee-Cig […]

I have avoided writing about the on-again, off-again takeover of AstraZeneca (LSE:AZN) by Pfizer (NYSE:PFE) simply because it has been on-gain, off-again. As of just a few minutes ago Pfizer released news and details of what it says is its final offer to AstraZeneca. In short, if this deal happens, it will be one of […]